相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia
Jianting Long et al.
BLOOD (2010)
Detection of gene pathways with predictive power for breast cancer prognosis
Shuangge Ma et al.
BMC BIOINFORMATICS (2010)
Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis
L. Bullinger et al.
LEUKEMIA (2010)
Origins and functional impact of copy number variation in the human genome
Donald F. Conrad et al.
NATURE (2010)
New Lesions Detected by Single Nucleotide Polymorphism Array-Based Chromosomal Analysis Have Important Clinical Impact in Acute Myeloid Leukemia
Ramon V. Tiu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis
D. Bowen et al.
LEUKEMIA (2009)
The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia
H. Seifert et al.
LEUKEMIA (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
Ina Radtke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Acquired copy number alterations in adult acute myeloid leukemia genomes
Matthew J. Walter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia
Lisa Kujawski et al.
BLOOD (2008)
Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia
Manoj Raghavan et al.
BLOOD (2008)
Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14
Peter Ouillette et al.
CANCER RESEARCH (2008)
250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
Andrew J. Dunbar et al.
CANCER RESEARCH (2008)
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study
Peter Paschka et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Monosomal karyotype in acute myeloid leukemia:: A better indicator of poor prognosis than a complex karyotype
Dimitri A. Breems et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype
C. Haferlach et al.
LEUKEMIA (2008)
Cooperating gene mutations in acute myeloid leukemia: a review of the literature
A. Renneville et al.
LEUKEMIA (2008)
Genetics of therapy-related myelodysplasia and acute myeloid leukemia
J. Pedersen-Bjergaard et al.
LEUKEMIA (2008)
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F. Schlenk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease
Kajsa Paulsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray
Norihiko Kawamata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia
Chris Saddler et al.
BLOOD (2008)
Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML
Lukasz P. Gondek et al.
BLOOD (2008)
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes
Azim Mohamedali et al.
BLOOD (2007)
Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis
Charles W. Ross et al.
CLINICAL CANCER RESEARCH (2007)
DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups
J. Suela et al.
LEUKEMIA (2007)
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2007)
Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization
Frank G. Ruecker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
Christian Thiede et al.
BLOOD (2006)
High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration
K Paulsson et al.
LEUKEMIA (2006)
Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias
J Fitzgibbon et al.
CANCER RESEARCH (2005)
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse
A Weltermann et al.
LEUKEMIA (2004)
Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia
S Casas et al.
CANCER GENETICS AND CYTOGENETICS (2004)
Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML
C Schoch et al.
LEUKEMIA (2004)
dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data
M Lin et al.
BIOINFORMATICS (2004)
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series
SM Smith et al.
BLOOD (2003)
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461)
JC Byrd et al.
BLOOD (2002)